Diploma PLC
LSE:DPLM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Diploma PLC
Cash Equivalents
Diploma PLC
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Diploma PLC
LSE:DPLM
|
Cash Equivalents
£81.7m
|
CAGR 3-Years
25%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
14%
|
|
|
Howden Joinery Group PLC
LSE:HWDN
|
Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bunzl plc
LSE:BNZL
|
Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Travis Perkins PLC
LSE:TPK
|
Cash Equivalents
£426.9m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
18%
|
|
|
Ashtead Group PLC
LSE:AHT
|
Cash Equivalents
$39.6m
|
CAGR 3-Years
10%
|
CAGR 5-Years
16%
|
CAGR 10-Years
23%
|
|
|
RS Group PLC
LSE:RS1
|
Cash Equivalents
£147.7m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
Diploma PLC
Glance View
Diploma PLC, a British company with a rich history, is known for its unique approach to adding value in otherwise niche markets since its inception in 1931. The company thrives on its strategy of acquiring and nurturing small-to-medium enterprises and integrating them into its core business areas—Life Sciences, Seals, and Controls. Each of these sectors functions with a tailored approach, yet all are intricately tied under the umbrella of specialisation and high-performance capabilities. In the Life Sciences business, Diploma supplies essential consumables and services to the healthcare and environmental industries, focusing on sectors where precision and dependability are paramount. Through its Seals business, it offers vital components and solutions to industries ranging from heavy mobile machinery to aerospace, while the Controls segment provides a broad array of wiring, cable, and related products. What sets Diploma PLC apart is its diversified revenue model coupled with a decentralized operating philosophy, allowing its businesses to maintain the agility of smaller entities while benefiting from the strength of a larger organization. Diploma’s well-practiced strategy of acquiring entrepreneurial companies, often family-owned, allows them to expand while retaining their unique DNA. The company then enhances these businesses by infusing operational efficiencies, leveraging its global reach, and encouraging best practice sharing across its decentralized network. This model not only stimulates organic growth but also ensures steady cash flow, resilience to market fluctuations, and sustainable profitability. In essence, Diploma PLC has carved out its niche by fostering growth through strategic acquisitions and operational excellence, ensuring its enduring success in specialised markets.
See Also
What is Diploma PLC's Cash Equivalents?
Cash Equivalents
81.7m
GBP
Based on the financial report for Sep 30, 2025, Diploma PLC's Cash Equivalents amounts to 81.7m GBP.
What is Diploma PLC's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
14%
Over the last year, the Cash Equivalents growth was 47%. The average annual Cash Equivalents growth rates for Diploma PLC have been 25% over the past three years , -17% over the past five years , and 14% over the past ten years .